QMC-16107-89668
1 vaccination
1 coded response
10 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 660 / KS
- Registered
- 2021-11-29
- Relationship
- Child or adolescent in my care
- Guardian
- A94-17509-11015
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-29
Registered in v-safe
-
2021-11-29
Dose 1 — Pfizer-BioNTech
- 2021-11-29
-
2021-11-30
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-12-03
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2021-12-06
- 2021-12-13
- 2021-12-20
- 2021-12-27
-
2022-02-28
Survey response — 3 months, dose 1, dependentMedDRA: Urticaria — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Reoccurring hives, no cause foundMedDRA releases: 2024-11 · check-in free text available
-
2022-02-28
Report sent to call center — 3 months, dose 1, dependentGet care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-02
- 2022-05-31
- 2022-11-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-29 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — 3 months, dose 1, dependent
Symptoms: Reoccurring hives, no cause found
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Urticaria | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release